Talzenna Interactions
There are 307 drugs known to interact with Talzenna (talazoparib), along with 3 disease interactions. Of the total drug interactions, 53 are major, and 254 are moderate.
- View all 307 medications that may interact with Talzenna
- View Talzenna disease interactions (3)
Most frequently checked interactions
View interaction reports for Talzenna (talazoparib) and the medicines listed below.
- acetaminophen
- Acid Reducer-Famotidine (famotidine)
- Aclasta (zoledronic acid)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- alendronate
- Alhemo (concizumab)
- Allegra (fexofenadine)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- Ambien (zolpidem)
- Brilinta (ticagrelor)
- calcium citrate
- clopidogrel
- docusate/senna
- Eliquis (apixaban)
- Kisqali (ribociclib)
- metoprolol
- ondansetron
- Truqap (capivasertib)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Xtandi (enzalutamide)
- Zepbound (tirzepatide)
Talzenna disease interactions
There are 3 disease interactions with Talzenna (talazoparib) which include:
Report options
More about Talzenna (talazoparib)
- Talzenna consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Pluvicto
Pluvicto (lutetium lu 177 vipivotide tetraxetan) is used for PSMA-positive metastatic ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
